
Dec 17 (Reuters) - Vyne Therapeutics Inc VYNE.O:
VYNE THERAPEUTICS AND YARROW BIOSCIENCE ANNOUNCE MERGER AGREEMENT
VYNE THERAPEUTICS INC - COMBINED COMPANY TO TRADE UNDER TICKER 'YARW'
VYNE THERAPEUTICS INC - PRE-CLOSING FINANCINGS OF $200 MILLION TO FUND OPERATIONS INTO 2028
VYNE THERAPEUTICS INC - COMBINED COMPANY TO BE NAMED YARROW BIOSCIENCE, LED BY REBECCA FREY
VYNE THERAPEUTICS - TO DECLARE CASH DIVIDEND TO PRE-MERGER VYNE STOCKHOLDERS OF $14.5 MILLION-$16.5 MILLION